Florida Biologix expands bioreactor and fill capacity
A recently completed manufacturing and filling capacity expansion will help Florida Biologix meet deadlines and win repeat business according to company director Richard Snyder.
Archives for January 11, 2010
API production starts at Evonik's new plant
Production has begun at the US API plant German chemicals firm Evonik Industries recently bought from drugmaker Eli Lilly.
GSK to shift Avodart production to Poland in 2011
GSK says it will start making its BPH drug Avodart (dutasteride) at its facility in Poznan, Poland when it completes a PLN70m (€17m) capacity upgrade in January next year.
WuXi partners to boost biomarkers
WuXi AppTec is partnering with Qiagen to develop biomarkers, assay panels and personalised healthcare diagnostics and will use these, and existing technologies, to further clients’ projects.
European ScreeningPort selects IDBS’ ActivityBase
European ScreeningPort is using IDBS’ ActivityBase XE to manage growing demand for screening services from the academic institutes which outsource to it.
FDA will miss Afrezza deadline; One small delay for MannKind?
US FDA has missed its review deadline for MannKind’s inhaled insulin candidate Afrezza after failing to complete inspection of third-party contract supplier.
Insect cells could cut vaccine production to 10 weeks
Vaccines could be produced in less than 10 weeks from first isolation of the RNA sequence by using insect cell derived influenza VLPs, according to research which has implications for H1N1 and H5N1.
Trial IRBs ERC and IRB to merge
US clinical trial review groups Independent Review Consulting (IRC) and Ethical Review Committee (ERC) are to merge and operate under the name Ethical and Independent Review Services (E&I).